KENDRA HARRIS: Open Payments
NPI 1083184345 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,406 in 67 payments from 11 companies in 2025. Trend: 2023 $895 · 2024 $1,582 · 2025 $1,406
Food & beverage: $1,406
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $262 |
| Itamar Medical Inc | 1 | $249 |
| Novo Nordisk Inc | 9 | $215 |
| Amgen Inc. | 29 | $213 |
| Recor Medical Inc | 1 | $117 |
| BridgeBio Pharma, Inc. | 3 | $90 |
| Merck Sharp & Dohme LLC | 4 | $86 |
| Regeneron Healthcare Solutions, Inc. | 4 | $83 |
| Alnylam Pharmaceuticals Inc. | 2 | $48 |
| Esperion Therapeutics, Inc. | 1 | $23 |
Products named: LEQVIO, WatchPATONE, REPATHA, Wegovy, Paradise Ultrasound Renal Denervation System, Attruby, EVKEEZA, Ozempic.
Industry payments across TX — which companies pay providers there.
